[Cefotaxime (klaforan) in modern therapy of bacterial infections].
Khess
R
R
Budanov
S V
SV
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000502:physiology; D002439:Cefotaxime / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002511:Cephalosporins / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000378:metabolism; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008826:Microbial Sensitivity Tests; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002439:Cefotaxime
Tsefotaksim (klaforan) v sovremennoĭ terapii bakterial'nykh infektsiĭ.